Laman UtamaRXRX • NASDAQ
Recursion Pharmaceuticals Inc
$6.88
13 Jan, 3:05:32 PG GMT-5 · USD · NASDAQ · Penafian
SahamSekuriti tersenarai ASIbu pejabat di AS
Tutup sebelumnya
$7.26
Julat hari
$6.78 - $7.08
Julat tahun
$5.60 - $15.74
Permodalan pasaran
2.69B USD
Bilangan Purata
16.46J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD)Sep 2024Perubahan T/T
Hasil
26.08J147.62%
Perbelanjaan pengendalian
37.76J29.31%
Pendapatan bersih
-95.84J-3.04%
Margin untung bersih
-367.4658.39%
Pendapatan bagi setiap syer
-0.3420.93%
EBITDA
-91.16J0.89%
Kadar cukai berkesan
-0.17%
Jumlah aset
Jumlah liabiliti
(USD)Sep 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
427.65J10.41%
Jumlah aset
726.50J15.17%
Jumlah liabiliti
201.94J4.71%
Jumlah ekuiti
524.56J
Syer tertunggak
286.84J
Harga kepada buku
3.97
Pulangan pada aset
-32.73%
Pulangan pada modal
-38.14%
Perubahan bersih dalam tunai
(USD)Sep 2024Perubahan T/T
Pendapatan bersih
-95.84J-3.04%
Tunai daripada operasi
-59.22J18.78%
Tunai daripada pelaburan
-4.56J-1,214.70%
Tunai daripada pembiayaan
16.46J-69.38%
Perubahan bersih dalam tunai
-46.92J-139.19%
Aliran tunai bebas
-16.60J70.89%
Perihal
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson. Wikipedia
Diasaskan
2013
Tapak web
Pekerja
500
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama